Greenstone Biosciences
  • Home
  • About
    • About Us
    • Company
    • Our Team
    • Partners
  • Our Products

    hiPSC-Derived Cells

    • iPSC - Academia
    • Ventricular Cardiomyocytes
    • Atrial Cardiomyocytes
    • Fibroblasts
    • Smooth Muscle Cells
    • Macrophages
    • Endothelial Cells
    • Epithelial Cells

    Organoids

    • Ventricular Cardiac Organoid
    • Atrial Cardiac Organoid
    • Pancreatic Islet Organoid
    • Gut Organoid
    • Vascularized Ventricular Cardiac Organoid
    • Vascularized Atrial Cardiac Organoid
  • Services
    • PBMC Collection and iPSC Reprogramming
    • Custom Differentiated iPSCs
    • Genetically Engineered iPSCs
    • High-Throughput Drug Discovery
    • Cell Village
    • Clinical Trial in a Dish
    • CARTOX (hERG Toxicity Assay)
    • Hepatotoxicity Screen
    • Functional assays of gut barrier Integrity and Disease Modelling.
    • Pancreatic Islet Organoid – Glucose Sensitivity
  • Pipeline
  • AI
    • AI
    • Admet Ai
  • Resources
    • Publications
    • Publications (Partners)
    • Webinars
    • News
    • Newsletter
    • LOS For Academic Researchers
    • Brochures
  • Investors
  • Careers
  • Quote
  • Contact
Join Us
0 items $0.00
Menu
Greenstone Biosciences
0 items $0.00

Posts by admin

HomeArticles Posted by admin
09 Apr
Blog

SDDS 2026: Stanford Drug Discovery Symposium

  • April 9, 2026
  • By author-avatar admin
Consistency counts. We don’t just show up; we invest. Greenst...

Continue reading

09 Apr
Blog

Greenstone Biosciences and Neolaia Bio Announce Strategic Collaboration Using iPSC-Derived Macrophages and Human Gut Organoids to Advance IBD Drug Development

  • April 9, 2026
  • By author-avatar admin
Greenstone Biosciences, a biotechnology company specializing in advanced human disease ...

Continue reading

09 Jan
Blog

Greenstone Biosciences is proud to be a sponsor of the 2023 Stanford Drug Discovery Symposium

  • February 23, 2026
  • By author-avatar admin
Greenstone Biosciences is a proud sponsor of the 2023 

Continue reading

27 Sep
Blog

Greenstone Biosciences Secures $2.75M to Advance Revolutionary Cardiotoxicity Detection Technology

  • February 23, 2026
  • By author-avatar admin
Published: Sep 13, 2023 PALO ALTO, CA — September 12, 2023 — Greenstone Biosc...

Continue reading

13 Jul
Blog

Congratulation to Greenstone Biosciences co-founder for becoming the President of American Heart Association

  • February 23, 2026
  • By author-avatar admin
Greenstone Biosciences is excited to announce that our distinguished co-founder, Dr. Jo...

Continue reading

01 Feb
Blog

Greenstone Biosciences on a Quest for Duchenne Muscular Dystrophy Therapeutics with New Funding from CIRM

  • February 23, 2026
  • By author-avatar admin
Palo Alto, CA, February 1, 2023 – Recently, the California Institute of Regenerative Me...

Continue reading

12 Dec
Blog

Greenstone co-founder Joseph Wu inducted into NAI Class of 2022

  • February 23, 2026
  • By author-avatar admin
We want to congratulate our co-founder 

Continue reading

07 Dec
Blog

CIRM funds Greenstone Biosciences with $1.35M to accelerate drug discovery using patient – derived induced pluripotent stem cells

  • February 23, 2026
  • By author-avatar admin
Greenstone Biosciences, Inc., a computational biology driven drug discovery company,

Continue reading

01 Dec
Blog

Greenstone Bio adds Axel Brunger to the Scientific Advisory Board

  • February 23, 2026
  • By author-avatar admin
Greenstone Biosciences would like to welcome Axel Brunger of Stanfo...

Continue reading

13 Oct
Blog

CIRM Awards $1.3 million to Greenstone Bio for Innovative Cardiovascular Stem Cell Research

  • February 23, 2026
  • By author-avatar admin
Palo Alto, CA, October 04, 2022 – Greenstone Biosciences, Inc. (“Greenstone Bio”),...

Continue reading

  • 1
  • 2
Greenstone Biosciences

Greenstone Biosciences accelerates drug discovery through human-relevant NAMs and advanced AI technologies. By combining scientific expertise with innovative platforms, we deliver safer, more effective therapies to patients in less time.

Quick Links

  • Home
  • About Us
  • hiPSC-Derived Cells
  • Organoids
  • Services
  • Pipeline

Services

  • AI
  • Publications
  • News
  • Webinars
  • Corporate
  • Contact Us

Contact Us

  • (650)714-7060
  • info@greenstonebio.com
  • Stanford Research Park 3160 Porter Drive, Suite 140 Palo Alto, CA 94304
Jki-twitter-light Jki-linkedin-light

© 2025 Greenstone Biosciences, Inc. All rights reserved.

  • Privacy Policy
  • Home
  • About
    • About Us
    • Company
    • Our Team
    • Partners
  • Our Products
    • hiPSC-Derived Cells
      • iPSC – Academia
      • Ventricular Cardiomyocytes
      • Atrial Cardiomyocytes
      • Fibroblasts
      • Smooth Muscle Cells
      • Macrophages
      • Endothelial Cells
      • Epithelial Cells
    • Organoids
      • Ventricular Cardiac Organoid
      • Atrial Cardiac Organoid
      • Pancreatic Islet Organoid
      • Gut Organoid
      • Vascularized Ventricular Cardiac Organoid
      • Vascularized Atrial Cardiac Organoid
  • Services
    • PBMC Collection and iPSC Reprogramming
    • Custom Differentiated iPSCs
    • Genetically Engineered iPSCs
    • High-throughput Drug Discovery
    • Cell Village
    • Clinical Trial in a Dish
    • CARTOX (hERG Toxicity Assay)
    • Hepatotoxicity Screen
    • Gut Organoid Permeability Assay
    • Pancreatic Islet Organoid – Glucose Sensitivity
  • Pipeline
  • AI
    • AI
    • Admet Ai
  • Resources
    • Publications
    • Publications (Partners)
    • Webinars
    • News
    • Newsletter
    • LOS For Academic Researchers
    • Brochures
  • Investors
  • Careers
  • Contact us
  • Login / Register
Shopping cart
Close